Trial Scorecards

Snapshot summaries of recent study results in cardiology.

Trial Scorecards

HELP-AF

Cardiology Today, November 2019
Outcomes of patients with AF who participated in a home-based structured educational program or received usual care.
Trial Scorecards

GALACTIC

Cardiology Today, November 2019
Potential noninferiority of pulmonary vein isolation vs. extensive ablation for persistent AF.
Trial Scorecards

EARNEST-PVI

Cardiology Today, November 2019
Potential noninferiority of pulmonary vein isolation vs. extensive ablation for persistent AF.
Trial Scorecards

ATTEST

Cardiology Today, November 2019
Radiofrequency ablation treatment vs. drug therapy to delay AF progression in patients with paroxysmal AF.
Trial Scorecards

THEMIS

Cardiology Today, October 2019
Researchers evaluated the effect of twice-daily ticagrelor (Brilinta, AstraZeneca) on CV death, MI or stroke in patients with type 2 diabetes.
Trial Scorecards

ORION-11

Cardiology Today, October 2019
Evaluation of the efficacy, safety and tolerability of a subcutaneous injection of inclisiran (The Medicines Company).
Trial Scorecards

PARAGON-HF

Cardiology Today, October 2019
Assessment of sacubitril/valsartan (Entresto, Novartis) vs. valsartan in patients with HF with preserved ejection fraction.
Trial Scorecards

ISAR-REACT 5

Cardiology Today, October 2019
Assessment of safety and efficacy of ticagrelor (Brilinta, AstraZeneca) vs. prasugrel (Effient, Daiichi Sankyo/Eli Lilly) in patients with ACS for…
Trial Scorecards

ENTRUST-AF PCI

Cardiology Today, October 2019
Researchers assessed bleeding risk of edoxaban (Savasya, Daiichi Sankyo) plus a P2Y12 inhibitor vs. a vitamin K antagonist, a P2Y12 inhibitor and…
Trial Scorecards

DEFINE-HF

Cardiology Today, October 2019
Researchers compared dapagliflozin (Farxiga, AstraZeneca) vs. placebo for HF-specific biomarkers, symptoms, health status and quality of life in…